Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year total asset growth rate
Latest
12.37%
↑ 1111% vs avg
Percentile
P85
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
1.02%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 12.37% |
| Q3 2025 | -3.01% |
| Q2 2025 | 1.19% |
| Q1 2025 | -7.63% |
| Q4 2024 | 17.79% |
| Q3 2024 | -8.48% |
| Q2 2024 | -16.94% |
| Q1 2024 | -15.89% |
| Q4 2023 | -5.28% |
| Q3 2023 | 13.09% |
| Q2 2023 | -8.88% |
| Q1 2023 | 20.17% |
| Q4 2022 | -7.38% |
| Q3 2022 | -6.84% |
| Q2 2022 | -5.90% |
| Q1 2022 | 6.67% |
| Q4 2021 | 0.20% |
| Q3 2021 | 3.79% |
| Q2 2021 | -2.26% |
| Q1 2021 | 25.78% |
| Q4 2020 | -12.25% |
| Q3 2020 | 1.99% |
| Q2 2020 | 18.43% |
| Q1 2020 | -5.25% |
| Q4 2019 | -1.47% |
| Q3 2019 | -5.21% |
| Q2 2019 | -3.01% |
| Q1 2019 | -5.85% |
| Q4 2018 | -0.98% |
| Q3 2018 | 45.82% |
| Q2 2018 | -1.93% |
| Q1 2018 | -3.76% |
| Q4 2017 | -0.03% |
| Q3 2017 | 2.64% |
| Q2 2017 | -0.64% |
| Q1 2017 | -2.84% |
| Q4 2016 | -1.34% |
| Q3 2016 | -0.29% |
| Q2 2016 | 5.30% |
| Q1 2016 | -1.03% |